Artiva Biotherapeutics, Inc. (ARTV)
5.80
-0.52
(-8.23%)
USD |
NASDAQ |
Mar 18, 16:00
5.82
+0.02
(+0.34%)
After-Hours: 06:54
Artiva Biotherapeutics Total Assets (Quarterly) : 134.57M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Rocket Pharmaceuticals, Inc. | 330.45M |
| Merck & Co., Inc. | 136.87B |
| Regeneron Pharmaceuticals, Inc. | 40.56B |
| Innoviva, Inc. | 1.635B |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 24.60M |
| Shareholders Equity (Quarterly) | 109.97M |
| Debt to Equity Ratio | 0.0995 |
| Current Ratio | 8.609 |
| Net Debt Paydown Yield | 0.76% |